(Q39873302)

15 September 2017

1 reference

title

Treatment of the cardiomyopathies (English)

1 reference

15 September 2017

Goodwin JF

1

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 1973

1 reference

American Journal of Cardiology

15 September 2017

published in

1 reference

15 September 2017

volume

32

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

341-351

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

15 September 2017

1 reference

Surgical relief of diffuse subvalvular aortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

SURGICAL TREATMENT AND POST-OPERATIVE HAeMODYNAMIC STUDIES IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Studies on digitalis. V. Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Hemogynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Long-term propranolol therapy in muscular subaortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Reversal of hemodynamic and phonocardiographic abnormalities in idiopathic hypertrophic subaortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

HAeMODYNAMIC EFFECTS OF CHANGES IN BLOOD VOLUME IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Prolonged bed rest in the treatment of the dilated heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Natural course of peripartum cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Idiopathic myocardial failure in the last trimester of pregnancy and the puerperium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Postpartum hypertensive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Ventricular hypertrophy in cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

7 January 2021

ALCOHOLIC HEART DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Primary myocardial disease and alcoholism. The clinical manifestations and course of the disease in a selected population of patients observed for three or more years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Effects of ethanol and acetaldehyde on the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Immunoglobulin binding in cardiomyopathic hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

CARDIAC FUNCTION IN PRIMARY MYOCARDIAL DISORDERS. I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

CARDIAC FUNCTION IN PRIMARY MYOCARDIAL DISORDERS II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

Acute mitral regurgitation in man. Hemodynamic evidence and observations indicating an early role for the pericardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980144-4

10.1016/S0002-9149(73)80144-4

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference